153 related articles for article (PubMed ID: 32657086)
41. Context matters for disability and priority setting for musculoskeletal diseases: revisiting the egalitarian approach to disability weights and disability-adjusted life-years.
Pigeolet M; Franco H; Nussbaum L; Corlew DS; Meara J
BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37311581
[TBL] [Abstract][Full Text] [Related]
42. The disease burden of childhood adversities in adults: a population-based study.
Cuijpers P; Smit F; Unger F; Stikkelbroek Y; Ten Have M; de Graaf R
Child Abuse Negl; 2011 Nov; 35(11):937-45. PubMed ID: 22099144
[TBL] [Abstract][Full Text] [Related]
43. [Estimation on the health life expectancy of adults in Zhejiang province, 2016].
Fei FR; Hu RY; Wang XY; Zhong JM; Gong WW; Pan J; Wu HB; Wang M; Wang H; Yu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Sep; 39(9):1249-1254. PubMed ID: 30293319
[No Abstract] [Full Text] [Related]
44. Measuring the burden of disease due to climate change and developing a forecast model in South Korea.
Yoon SJ; Oh IH; Seo HY; Kim EJ
Public Health; 2014 Aug; 128(8):725-33. PubMed ID: 25132390
[TBL] [Abstract][Full Text] [Related]
45. [Cause-excluded health adjusted life expectancy: a new indicator in measuring the burden of diseases].
Wang JS; Jin SG
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):655-8. PubMed ID: 20021841
[TBL] [Abstract][Full Text] [Related]
46. Estimating Lifetime Duration of Diabetes by Age and Gender in the Korean Population Using a Markov Model.
Cho SW; Kim SH; Kim YE; Yoon SJ; Jo MW
J Korean Med Sci; 2019 Mar; 34(Suppl 1):e74. PubMed ID: 30923487
[TBL] [Abstract][Full Text] [Related]
47. Describing the population health burden of depression: health-adjusted life expectancy by depression status in Canada.
Steensma C; Loukine L; Orpana H; McRae L; Vachon J; Mo F; Boileau-Falardeau M; Reid C; Choi BC
Health Promot Chronic Dis Prev Can; 2016 Oct; 36(10):205-213. PubMed ID: 27768557
[TBL] [Abstract][Full Text] [Related]
48. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.
India State-Level Disease Burden Initiative Collaborators
Lancet; 2017 Dec; 390(10111):2437-2460. PubMed ID: 29150201
[TBL] [Abstract][Full Text] [Related]
49. Disability weights for the Global Burden of Disease 2013 study.
Salomon JA; Haagsma JA; Davis A; de Noordhout CM; Polinder S; Havelaar AH; Cassini A; Devleesschauwer B; Kretzschmar M; Speybroeck N; Murray CJ; Vos T
Lancet Glob Health; 2015 Nov; 3(11):e712-23. PubMed ID: 26475018
[TBL] [Abstract][Full Text] [Related]
50. The national burden of cerebrovascular diseases in Spain: a population-based study using disability-adjusted life years.
Catalá-López F; Fernández de Larrea-Baz N; Morant-Ginestar C; Álvarez-Martín E; Díaz-Guzmán J; Gènova-Maleras R
Med Clin (Barc); 2015 Apr; 144(8):353-9. PubMed ID: 24863563
[TBL] [Abstract][Full Text] [Related]
51. Disease burden from COVID-19 symptoms among inpatients at the temporary military hospitals in Wuhan: a retrospective multicentre cross-sectional study.
He M; Li X; Tan Q; Chen Y; Kong Y; You J; Lin X; Lin Y; Zheng Q
BMJ Open; 2021 May; 11(5):e048822. PubMed ID: 34006559
[TBL] [Abstract][Full Text] [Related]
52. Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
Lubeck D; Agodoa I; Bhakta N; Danese M; Pappu K; Howard R; Gleeson M; Halperin M; Lanzkron S
JAMA Netw Open; 2019 Nov; 2(11):e1915374. PubMed ID: 31730182
[TBL] [Abstract][Full Text] [Related]
53. Economic Burden and Disability-Adjusted Life Years (DALYs) of Attention Deficit/Hyperactivity Disorder.
Hong M; Park B; Lee SM; Bahn GH; Kim MJ; Park S; Oh IH; Park H
J Atten Disord; 2020 Apr; 24(6):823-829. PubMed ID: 31364445
[No Abstract] [Full Text] [Related]
54. Estimation of Disability Weights in the General Population of South Korea Using a Paired Comparison.
Ock M; Ahn J; Yoon SJ; Jo MW
PLoS One; 2016; 11(9):e0162478. PubMed ID: 27606626
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of switching to biphasic insulin aspart 30 from human insulin in patients with poorly controlled type 2 diabetes in South Korea.
Lee KH; Seo SJ; Smith-Palmer J; Palmer JL; White J; Valentine WJ
Value Health; 2009; 12 Suppl 3():S55-61. PubMed ID: 20586983
[TBL] [Abstract][Full Text] [Related]
57. Adjusting for dependent comorbidity in the calculation of healthy life expectancy.
Mathers CD; Iburg KM; Begg S
Popul Health Metr; 2006 Apr; 4():4. PubMed ID: 16620383
[TBL] [Abstract][Full Text] [Related]
58. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
[TBL] [Abstract][Full Text] [Related]
59. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.
Cross M; Smith E; Hoy D; Nolte S; Ackerman I; Fransen M; Bridgett L; Williams S; Guillemin F; Hill CL; Laslett LL; Jones G; Cicuttini F; Osborne R; Vos T; Buchbinder R; Woolf A; March L
Ann Rheum Dis; 2014 Jul; 73(7):1323-30. PubMed ID: 24553908
[TBL] [Abstract][Full Text] [Related]
60. Burden of Cancers in Iran from 1990 to 2010: findings from the Global Burden of Disease study 2010.
Modirian M; Rahimzadeh S; Cheraghi Z; Saeedi Moghaddam S; Rezaei N; Tohidinik HR; Kasaeian A; Jamshidi HR; Ghobadi R; Kompani F
Arch Iran Med; 2015 Oct; 18(10):629-37. PubMed ID: 26443246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
